| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | -4.82% | +0.53% | -5.35% | -3.66% | — |
| 14d | 4 | +75.00% | +1.01% | +3.93% | -2.92% | -3.16% | — |
| 30d | 4 | +25.00% | +3.57% | +8.38% | -4.81% | -17.66% | — |
| 60d | 4 | +25.00% | +20.42% | +7.29% | +13.13% | -10.65% | — |
| 90d | 4 | +25.00% | +27.93% | +12.00% | +15.93% | -13.10% | — |
| 180d | 4 | +25.00% | +1.30% | +17.51% | -16.21% | -22.10% | — |
| 1y | 4 | +75.00% | +42.39% | +31.43% | +10.96% | +23.20% | — |
| 2y | 4(1 pending) | +66.67% | -13.11% | +63.50% | -76.61% | -35.06% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| COYA COYA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,041 | — | — | 140,041 | Jan 22, 2026 | Jan 26, 2026 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,562 | — | — | 140,562 | Jan 9, 2025 | Jan 13, 2025 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,800 | $7.19 | $12.9K | 8,800 | Nov 14, 2024 | Nov 14, 2024 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,596 | — | — | 70,596 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 81,819 | — | — | 81,819 | Jan 31, 2024 | Feb 2, 2024 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,000 | — | — | 115,000 | Feb 27, 2023 | Mar 1, 2023 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,000 | — | — | 7,000 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| COYA COYA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,500 | — | — | 3,500 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| XCUR EXICURE, INC. | PURCHASEGRANT Stock grant | 230,200 | — | — | 230,200 | Mar 13, 2020 | Mar 16, 2020 ↗ | View → |
| XCUR EXICURE, INC. | PURCHASE Chief Financial Officer | 18,248 | $1.40 | $25.6K | 18,248 | Mar 12, 2020 | Mar 16, 2020 ↗ | View → |